• Acute Lymphoblastic Leukemia: Nursing Notes on Asparaginase Hypersensitivity and Silent Inactivation

What's New

Newsletters
BTK inhibitors in CLL and MCL: Strategies for Managing Adverse Events
Julie M. Vose, MD, MB; Jeremy R. Stone, MD; Nicole Lamanna, MD; Peter Campbell, PharmD, BCOP
CE Education
Multidisciplinary Perspectives on BTK Inhibitors Adverse Events Management in CLL and MCL
Julie M. Vose, MD, MB – Chair; Jeremy R. Stone, MD; Nicole Lamanna, MD; Peter Campbell, PharmD, BCOP
Newsletters
Caring for Patients with CLL in Rural America
Satish Shanbhag, MD, MPH, FACP
CE Education
BTK inhibitors in CLL and MCL: Strategies for Managing Adverse Events
Farrukh T. Awan, MD; Alan Morgan, MPA; Opal H. Greenway, JD
Newsletters
The Epidemiology of CLL in Rural America
Gary G. Schwartz, PhD, MPH